(27 days)
No
The document describes "TruTrak+ motion correction performance technology" but does not mention AI, ML, or any related concepts. The description focuses on hardware components and standard performance metrics.
No
Explanation: The device monitors arterial oxygen saturation and pulse rate but does not provide any therapeutic intervention or treatment.
Yes
The device monitors arterial oxygen saturation and pulse rate, providing physiological measurements used to assess a patient's condition, which aligns with the function of a diagnostic device.
No
The device description explicitly states it is a "single-width plug-in parameter module" and includes hardware components like LEDs, a photodetector, a measurement board, and an interface board.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to monitor arterial oxygen saturation of hospitalized patients. This is a physiological measurement taken directly from the patient's body using a sensor (light wavelengths LEDs and photodetector).
- Device Description: The device is a module that measures noninvasive arterial oxygen saturation and pulse rate. It uses a sensor placed on the patient.
- Lack of In Vitro Activity: An IVD device is intended for use in vitro (outside the body) to examine specimens derived from the human body (like blood, urine, tissue). This device does not analyze such specimens. It directly measures a physiological parameter in vivo (within the body).
Therefore, the Datex-Ohmeda S/5™ Oxygen Saturation Module, M-OSAT is a patient monitoring device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Datex-Ohmeda S/5™ Oxygen Saturation Module, M-OSAT is intended for use with The Datex-Ohmeda modular multiparameter patient monitors for monitoring arterial oxygen saturation of hospitalized patients.
The Datex-Ohmeda S/5™ Oxygen Saturation Module, M-OSAT, and accessories are indicated for monitoring arterial oxygen saturation of hospitalized patients including monitoring during conditions of clinical patient motion. The device is indicated for use by qualified medical personnel only.
Product codes
74 DQA
Device Description
The Datex-Ohmeda Oxygen Saturation Module, M-OSAT and accessories with TruTrak+ motion correction performance (later referred to as M-OSAT) is a module used to monitor arterial oxygen saturation. The user interface has been implemented in the main software of the following:
- · AS/3 Anesthesia Monitor (K933285)
- · AS/3 Compact Monitor (K933156) using S-STDxx or S-ARKxx software
- · CS/3 Monitors (K974792) using S-ICUxx software
- · AS/3 Anesthesia Monitor (K000815) using S-ANE99(A), L-ARK99(A)
- · S/5 Compact Anesthesia Monitor (K002478) using S-00A05, S-00A06, L-00A07, L-00A08 software
- · S/5 Compact Critical Care Monitor (K002158) using S-00C03, S-00C04 software.
M-OSAT is single-width plug-in parameter module including the arterial oxygen saturation and pulse rate measurements for a modular monitoring system. This module is designed with the following characteristics:
- a single width plug-in module for the S/5 multiparameter monitor .
- measuring noninvasive arterial oxygen saturation and pulse rate .
- sensor consists of two light wavelengths LEDs and photodetector .
- Datex-Ohmeda proprietary SpO2 measurement board Prologue .
- an interface board for connecting the measurement board to the monitor .
- uses TruTrak+ with motion performance correction technology for measuring . noninvasive arterial oxygen saturation during clinical motion
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
qualified medical personnel only.
hospitalized patients
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Datex-Ohmeda Oxygen Saturation Module, M-OSAT and accessories (with TruTrak+ The Datex-Onlineda Oxygen Salaranoly with the safety standards below and is therefore safe and effective for the intended use. The device has been thoroughly tested including sale and enced ve for the necessic compatibility, mechanical and environmental tolerance, electrical sarely, clouromagnetic compsiterions. Verification of compliance with the following mandatory and voluntary standards has been made:
- IEC 60601-1: 1988 + Amdt 1:1991, Amdt 2:1995 .
- EN 60601-1: 1990+ Amendments: A1: 1993, A2: 1995, A13: 1996 .
- CAN/CSA C22.2 No. 601-1-M90 + S1 (1994)+Amdt2:1998 .
- · UL 2601-1: 1997
- · IEC 60601-1-2: 1993
- FDA Reviewer Guidance for premarket notification submissions: 1993 .
- IEC 60601-1-4: 1996 .
- ANSI/AAMI ES1 (1993) .
- IEC 601-2-26 (1994) .
- ISO 9919: 1992
- · EN 865:1997
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
has the same accuracy and measuring range, with the exception of the additional specification 70% - 100% +/-3 digits under clinical motion conditions
Predicate Device(s)
Reference Device(s)
K933285, K933156, K974792, K000815, K002478, K002158
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
JUN 2 6 2001
Image /page/0/Picture/1 description: The image shows a black and white logo. The logo consists of a large black circle with a white letter "D" inside. There is a small black square in the upper right corner of the circle.
Premarket Notification 510(k) Summary As required by section 807.92 Datex-Ohmeda Oxygen Saturation Module, M-OSAT and accessorles (with TruTrak+ motion correction performance)
Page 1 of 4
11670
GENERAL COMPANY INFORMATION as required by 807.92(a)(1)
COMPANY NAME/ADDRESS/PHONE/FAX:
Datex-Ohmeda, Inc. 3 Highwood Drive Tewksbury, MA 01876 Tel: 978-640-0460 Fax: 978-640-0469
NAME OF CONTACT: Mr. Joel Kent FDA Official Correspondent
DATE:
May 26, 2001
DEVICE NAME as required by 807.92(a)(2)
TRADE NAME:
Datex-Ohmeda Oxygen Saturation Module, M-OSAT and accessories (with TruTrak+ motion correction performance)
COMMON NAME:
Oxygen Saturation Measurement Module, SPO2 Accessories
CLASSIFICATION NAME:
The following Class II classifications appear applicable:
Oximeter (per 21 CFR 870.2700) Ear Oximeter (per 21 CFR 870.2710)
Datex-Ohmeda, Inc. Three Highwood Drive Tewksbury, MA 01876 www.datex.ohmeda.com Telephone: 800-635-6099 978-640-0460 Facsimile: 978-640-0469
1
NAME OF LEGALLY MARKETED DEVICE FOR WHICH A CLAIM OF SUBSTANTIAL EQUIVALENCE IS MADE as required by 807.92(a)(3)
The Datex-Ohmeda Oxygen Saturation Module, M-OSAT and accessories (with TruTrak+ motion correction performance) is substantially equivalent in safety and effectiveness to the legally marketed (predicate) Datex-Ohmeda Oxygen Saturation Module, M-OSAT and accessories (K010463).
DEVICE DESCRIPTION as required by 807.92(a)(4)
The Datex-Ohmeda Oxygen Saturation Module, M-OSAT and accessories with TruTrak+ motion correction performance (later referred to as M-OSAT) is a module used to monitor arterial oxygen saturation. The user interface has been implemented in the main software of the following:
- · AS/3 Anesthesia Monitor (K933285)
- · AS/3 Compact Monitor (K933156) using S-STDxx or S-ARKxx software
- · CS/3 Monitors (K974792) using S-ICUxx software
- · AS/3 Anesthesia Monitor (K000815) using S-ANE99(A), L-ARK99(A)
- · S/5 Compact Anesthesia Monitor (K002478) using S-00A05, S-00A06, L-00A07, L-00A08 software
- · S/5 Compact Critical Care Monitor (K002158) using S-00C03, S-00C04 software.
M-OSAT is single-width plug-in parameter module including the arterial oxygen saturation and pulse rate measurements for a modular monitoring system. This module is designed with the following characteristics:
- a single width plug-in module for the S/5 multiparameter monitor .
- measuring noninvasive arterial oxygen saturation and pulse rate .
- sensor consists of two light wavelengths LEDs and photodetector .
- Datex-Ohmeda proprietary SpO2 measurement board Prologue .
- an interface board for connecting the measurement board to the monitor .
- uses TruTrak+ with motion performance correction technology for measuring . noninvasive arterial oxygen saturation during clinical motion
2
INTENDED USE as required by 807.92(a)(5)
The Datex-Ohmeda S/5™ Oxygen Saturation Module, M-OSAT is intended for use with The Datex-Ohmeda modular multiparameter patient monitors for monitoring arterial oxygen saturation of hospitalized patients.
The Datex-Ohmeda S/5™ Oxygen Saturation Module, M-OSAT, and accessories are I ne Dates Onlineda UP - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - monitoring during conditions of clinical patient motion. The device is indicated for use by qualified medical personnel only.
SUMMARY OF TECHNOLOGICAL CHARACTERITICS OF DEVICE COMPARED TO THE PREDICATE DEVICE as required by 807.92(a)(6)
The Datex-Ohmeda Oxygen Saturation Module, M-OSAT is substantially equivalent in safety and effectiveness to the legally marketed (predicate) M-OSAT Oxygen Saturation Module, (K010463).
The modified M-OSAT module has the following similarities and differences compared to the previously cleared M-OSAT (K010463) predicate device:
- has the same indicated use, except with the addition of the phrase "including monitoring during conditions of clinical patient motion."
- · uses the same operating principle, and the same electronic circuitry with the minor exception of a passive electrical component that was added to the Prologue board
- · has the same safety and effectiveness
- · has the same user interface and alarms, with the exception of the additional messages " 250" for Pulse Rate range violations.
- · has the same accuracy and measuring range, with the exception of the additional specification 70% - 100% +/-3 digits under clinical motion conditions
- · uses the same accessories with the exception of three new OxyTip+ sensors that were added to replace previous devices
- Interface board software was updated .
- are manufactured using the same processes .
The modified Datex-Ohmeda Oxygen Saturation Module, M-OSAT, has the same intended use and indication for use as the previously cleared device, with the exception noted above.
The M-OSAT units are both intended for use with the Datex-Ohmeda modular multiparameter patient monitoring arterial oxygen saturation of hospitalized patients. Both are indicated for use by qualified medical personnel only.
The M-OSAT units both have the same user interface and alarm logic as the monitor, with the exception noted above. The data of both modules are receiving and showing on the monitor screen similar. Alarms of both modules have the same alarm menus and alarms can be adjusted equally.
3
The main differences between M-OSAT and the predicate are primarily due to fact that M-The maill differences betweed "TruTrak+" pulse oximetry technology to improve motion correction performance versus the predicate.
In summary, the Oxygen Saturation Module, M-OSAT, described in this submission is substantially equivalent to the predicate device
SUMMARY OF NONCLINICAL TESTING FOR THE DEVICE and CONCLUSIONS as required by 807.92(b)(1)(3)
The Datex-Ohmeda Oxygen Saturation Module, M-OSAT and accessories (with TruTrak+ The Datex-Onlineda Oxygen Salaranoly with the safety standards below and is therefore safe and effective for the intended use. The device has been thoroughly tested including sale and enced ve for the necessic compatibility, mechanical and environmental tolerance, electrical sarely, clouromagnetic compsiterions. Verification of compliance with the following mandatory and voluntary standards has been made:
- IEC 60601-1: 1988 + Amdt 1:1991, Amdt 2:1995 .
- EN 60601-1: 1990+ Amendments: A1: 1993, A2: 1995, A13: 1996 .
- CAN/CSA C22.2 No. 601-1-M90 + S1 (1994)+Amdt2:1998 .
- · UL 2601-1: 1997
- · IEC 60601-1-2: 1993
- FDA Reviewer Guidance for premarket notification submissions: 1993 .
- IEC 60601-1-4: 1996 .
- ANSI/AAMI ES1 (1993) .
- IEC 601-2-26 (1994) .
- ISO 9919: 1992
- · EN 865:1997
Conclusion:
The summary above shows that there are no new questions of safety and effectiveness for Phe Sammeda Oxygen Saturation Module, M-OSAT and accessories (with TruTrak+ motion correction performance) as compared to the predicate device.
4
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or bird in flight. The symbol is composed of three curved lines that suggest wings and a body.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 2 6 2001
Mr. Joel Kent Datex Ohmeda, Inc. 3 Highwood Drive Tewksbury, MA 01876
Re: K011670
Datex-Ohmeda S/5TM Oxygen Saturation Module, M-OSAT, and accessories (with TruTrak+ Motion Correction Performance) Regulation Number: 870.2700 Regulatory Class: II (two) Product Code: 74 DQA Dated: May 27, 2001 Received: May 30, 2001
Dear Mr. Kent:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this
5
Page 2 - Mr. Joel Kent
response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours.
Don K. Tellh
James E. Dillard III Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
KOII670 510(k) Number (if known): _
Device Name: Datex-Ohmeda S/5™ Oxygen Saturation Module, M-OSAT, and accessories (with TruTrak+ Motion Correction Performance)
The Datex-Ohmeda S/5™ Oxygen Saturation Module, M-OSAT, and accessories are indicated for monitoring arterial oxygen saturation of hospitalized patients including monitoring during conditions of clinical patient motion. The device is indicated for use by qualified medical personnel only.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use | ✓ |
|---|---|
| (Per 21 CFR 801.109) |
OR
| Over-The-Counter Use | |
|---|---|
| (Optional Format 1-2-96) |
Division of Cardiovascular & Respiratory Devices510(k) Number